netFormulary
 Report : A-Z HCD items in Formulary 17/02/2020 23:56:02
[Back]
 
Section Status CCG Name
13.05.03 Restricted Use CCG Certolizumab pegol 
13.05 Restricted Use CCG Dupilumab Dupixent
13.05.03 Restricted Use CCG Risankizumab Skyrizi
01.05 Restricted Use CCG Tofacitinib XELJANZ
10.01.03 Restricted Use CCG Tofacitinib XELJANZ
Leicestershire Health Community